EUVIMEDEUVIMED entdecken
Crossref

Association of PIK3CA mutations with brainstem location in sporadic cerebral cavernous malformations

Martin Planet, Yohan Ducos, Mélanie Eyries, Pauline Marijon, Franck Bielle, Lucas Rincon de la Rosa, Agusti Alentorn, Bertrand Mathon, Florence Coulet, Michel Kalamarides, Matthieu Peyre

Journal of Neurosurgery · 2025

DOI: 10.3171/2025.5.jns25596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurosurgery, 2025. Verfasst von Martin Planet und 10 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Neurosurgery, Sorbonne Université, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris. Hauptthemen laut MEDLINE: Class I Phosphatidylinositol 3-Kinases, Hemangioma, Cavernous, Central Nervous System, Mutation, Brain Stem. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Since 2021, there has been a revolution in the understanding of the mutational landscape of sporadic cerebral cavernous malformations (CCMs), with the key discovery of somatic mutations in the PIK3CA and MAP3K3 genes. These genetic alterations have provided new insights into the pathophysiology of CCMs and opened potential venues for personalized treatments. However, establishing robust clinicoradiological and molecular correlations is essential to guide targeted therapeutic approaches and optimize patient outcomes. METHODS This study included a cohort of 89 patients diagnosed with sporadic CCMs. The mutational status of each patient was determined using next-generation sequencing (NGS) targeting known mutations including the PIK3CA, MAP3K3 , and CCM genes. NGS findings were confirmed by droplet digital polymerase chain reaction for PIK3CA and MAP3K3 mutations. Clinical and radiological data, including Zabramski classification data, were systematically recorded. Statistical analysis was performed to identify significant clinicoradiological and molecular correlations. RESULTS In the cohort, PIK3CA somatic mutations were identified in 43 patients (48%), while MAP3K3 somatic mutations were found in 29 (33%). Clinically, PIK3CA -mutated lesions were less frequently revealed by intracranial hypertension (9.3% vs 19.6%; adjusted OR 0.09, p = 0.006), while for MAP3K3 -mutated lesions, seizure as a mode of onset was significantly more frequent (85.7% vs 51.7%, p = 0.002). Radiologically, midline lesions were significantly more frequent in the PIK3CA -mutated group (19.0% vs 2.2%, p = 0.01). Importantly, in univariate analysis, the presence of a brainstem lesion was a significant independent predictor of PIK3CA somatic mutation (14.3% vs 2.2%; unadjusted OR 7.33, p = 0.03). CONCLUSIONS This study presents new findings linking genetic mutations with clinicoradiological features in sporadic CCMs. The significant association of PIK3CA somatic mutations with brainstem location highlights a potential avenue for personalized therapeutic strategies targeting this mutation, considering the significantly increased morbidity and surgical challenge associated with brainstem lesions. These findings reinforce the importance of integrating genetic data into clinical practice to improve patient outcomes and develop new therapies for CCMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Class I Phosphatidylinositol 3-KinasesHemangioma, Cavernous, Central Nervous SystemMutationBrain StemHumansFemaleMaleAdultMiddle AgedYoung AdultAdolescentAgedMAP Kinase Kinase Kinase 3Cohort StudiesChildHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

MAP3K3PIK3CAbrainstemcavernomacerebral cavernous malformationepilepsygeneticsvascular disorders

Substanzen

PIK3CA protein, humanClass I Phosphatidylinositol 3-KinasesMAP Kinase Kinase Kinase 3MAP3K3 protein, human

Autor:innen und Institutionen

  • 1Department of Neurosurgery, Sorbonne Université, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris.
  • 2Neurovascular interfaces in Brain Tumors and Vascular malformations, CRICM INSERM U1127 CNRS UMR7225, Brain Institute, Hôpital de la Pitié-Salpêtrière, Paris.
  • 3Department of Medical Genetics, Sorbonne Université, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris.
  • 4Department of Neuropathology, Sorbonne Université, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris; and.
  • 5Brain Tumor Heterogeneity, CRICM INSERM U1127 CNRS UMR7225, Brain Institute, Hôpital de la Pitié-Salpêtrière, Paris, France.

Zitieren

APA

Planet, M., Ducos, Y., Eyries, M., Marijon, P., Bielle, F., Rincon de la Rosa, L., Alentorn, A., Mathon, B., Coulet, F., Kalamarides, M., & Peyre, M. (2025). Association of PIK3CA mutations with brainstem location in sporadic cerebral cavernous malformations. Journal of Neurosurgery. https://doi.org/10.3171/2025.5.jns25596

Vancouver

Planet M, Ducos Y, Eyries M, Marijon P, Bielle F, Rincon de la Rosa L, et al. Association of PIK3CA mutations with brainstem location in sporadic cerebral cavernous malformations. Journal of Neurosurgery. 2025. doi:10.3171/2025.5.jns25596

BibTeX
@article{Planet2025,
  author = {Planet, Martin and Ducos, Yohan and Eyries, Mélanie and Marijon, Pauline and Bielle, Franck and Rincon de la Rosa, Lucas and Alentorn, Agusti and Mathon, Bertrand and Coulet, Florence and Kalamarides, Michel and Peyre, Matthieu},
  title = {Association of PIK3CA mutations with brainstem location in sporadic cerebral cavernous malformations},
  journal = {Journal of Neurosurgery},
  year = {2025},
  doi = {10.3171/2025.5.jns25596}
}
Kostenlos starten →